Avantor, Inc. (AVTR)

Market Cap	13.98B
Revenue (ttm)	6.87B
Net Income (ttm)	260.00M
Shares Out	679.27M
EPS (ttm)	0.38
PE Ratio	54.16
Forward PE	18.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,074,420
Open	20.62
Previous Close	20.77
Day's Range	20.49 - 20.71
52-Week Range	16.63 - 26.16
Beta	1.35
Analysts	Buy
Price Target	26.25 (+27.55%)
Earnings Date	Jul 26, 2024

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Specialty Chemicals
• Sector: Materials
• IPO Date: May 17, 2019
• Employees: 7,570
• Stock Exchange: NYSE
• Ticker Symbol: AVTR

Financial Performance

In 2023, Avantor's revenue was $6.97 billion, a decrease of -7.26% compared to the previous year's $7.51 billion. Earnings were $321.10 million, a decrease of -51.52%.

Analyst Forecast

According to 18 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $26.25, which is an increase of 27.55% from the latest price.

Price Target

$26.25

(27.55% upside)

Analyst Consensus: Buy